Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
McKinsey
Baxter
Dow
Federal Trade Commission
Accenture
Cerilliant
AstraZeneca

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SPIRIVA

« Back to Dashboard

Clinical Trials for Spiriva

Trial ID Title Status Sponsor Phase Summary
NCT00144196 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) Completed Boehringer Ingelheim Phase 4 To show that treatment with tiotropium inhalation capsules (18 μg q.d.) via HandiHaler® improves lung function in patients with mild COPD according to Swedish guidelines.
NCT00144326 A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (CO Completed Boehringer Ingelheim Phase 3 The objective of this study is to determine if tiotropium (Spiriva, Bromuro de Tiotropio) 18 mcg once daily by oral inhalation compared to placebo increases the magnitude of daily physical activity observed in COPD patients, measured using an accelerometer.
NCT00144339 Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients Completed Boehringer Ingelheim Phase 3 The primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate of decline in lung function over time in patients with COPD.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Spiriva

Condition Name

Condition Name for Spiriva
Intervention Trials
Pulmonary Disease, Chronic Obstructive 40
Chronic Obstructive Pulmonary Disease 17
COPD 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Spiriva
Intervention Trials
Pulmonary Disease, Chronic Obstructive 68
Lung Diseases 67
Chronic Disease 40
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Spiriva

Trials by Country

Trials by Country for Spiriva
Location Trials
United States 486
Canada 62
Germany 32
Australia 30
China 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Spiriva
Location Trials
South Carolina 26
California 24
Florida 24
North Carolina 23
Ohio 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Spiriva

Clinical Trial Phase

Clinical Trial Phase for Spiriva
Clinical Trial Phase Trials
Phase 4 32
Phase 3 26
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Spiriva
Clinical Trial Phase Trials
Completed 72
Recruiting 7
Terminated 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Spiriva

Sponsor Name

Sponsor Name for Spiriva
Sponsor Trials
Boehringer Ingelheim 46
Pearl Therapeutics, Inc. 9
Pfizer 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Spiriva
Sponsor Trials
Industry 92
Other 26
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Medtronic
McKinsey
Fish and Richardson
US Army
Boehringer Ingelheim
McKesson
AstraZeneca
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.